Alembic Pharmaceuticals receives USFDA approval for Diltiazem Hydrochloride ER capsules
Alembic Pharmaceuticals (Alembic) announced that it has received Final Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem ...
Alembic Pharma gets US FDA nod for Diltiazem Hydrochloride ER capsules
Alembic Pharmaceuticals said that it has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Diltiazem Hydrochloride ...
The Financial Express25 天
USFDA gives nod to Alembic Pharma’s generic formulation to treat heart disorder
for its Abbreviated New Drug Application (ANDA) Diltiazem Hydrochloride Extended-Release Capsules USP, 120 mg, 180 mg, and 240 mg. According to the company’s statement, the approved ANDA is ...
The Financial Express4 天
USFDA gives nod to Alembic Pharma for its generic formulation to treat hypertension
for its Abbreviated New Drug Application (ANDA) for Diltiazem Hydrochloride Extended-Release Capsules USP, 120 mg, 180 mg, 240 mg, 300 mg, and 360 mg. According to company’s statement ...